Some commonly prescribed drugs are associated with a high risk of sudden cardiac arrest in people with type 2 diabetes 5th October 2023
Tirzepatide effective at treating younger and older people with type 2 diabetes, professor finds 5th October 2023
Semaglutide improves blood sugar control and weight loss in adults with type 2 diabetes for up to three years 5th October 2023
Semaglutide to eliminate mealtime insulin injections in people with type 1 diabetes 12th September 2023
Semaglutide reduces risk of major adverse cardiovascular events in adults with overweight or obesity 15th August 2023
New medication combination triggers weight loss and good blood sugar control in people with type 2 diabetes 17th July 2023
Menarini becomes exclusive distributor for INVOKANA® (canagliflozin) and VOKANAMET® (fixed-dose combination of canagliflozin and metformin) in the UK 13th July 2023
ADA 2023 NEWS: Tirzepatide achieves average weight reduction of 15.7% at highest dose in adults with obesity and type 2 diabetes 28th June 2023
